Search

everythinglearnresearchcommunity

for

Search:↓

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

Double-stranded RNA causes inflammation in hair follicle cells, which may help understand and treat alopecia areata.

TH antibodies in vitiligo and AA patients recognize the same protein parts.

Hair loss in male pattern baldness is linked to changes in immune cell behavior around hair follicles.

Topical immunotherapy for alopecia areata may work by creating immune cell clusters in the skin.

Blocking interferon-gamma helps prevent and treat hair loss in Alopecia Areata.

Blocking LFA-1 prevents hair loss in mice.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

Alopecia areata involves immune system imbalances that may lead to depression and anxiety.

NKG2D+CD4+ T cells are higher in alopecia areata patients and may be involved in the disease.

Different γδ T cell types have unique roles in causing alopecia areata.

The study found that alopecia areata is strongly linked to autoimmune diseases and may indicate a genetic predisposition to such conditions.

Atopic dermatitis may trigger alopecia areata, and early treatment can help prevent severe cases.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

Regular monitoring of autoantibodies in ANA-positive patients with hair loss helps detect and treat lupus early.

Alopecia areata and atopic dermatitis share immune system issues, and treatments like JAK inhibitors can help both.

Vitiligo and alopecia areata may have similar causes despite their differences.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

Cell-based therapy using specific immune cells may help treat alopecia areata by promoting hair regrowth.

Alopecia areata is a reversible, autoimmune-related hair loss that can have significant emotional impact and uncertain treatment effectiveness.

Immune cells and plasma proteins are linked to hair loss, suggesting new treatment options.

Alopecia areata patients have fewer protective regulatory B cells, which may contribute to the disease.

Chronic refractory alopecia areata has more skin-resident memory T cells, and JAK inhibitors may help reduce them.

Personalized homeopathic treatment can effectively promote hair regrowth in autoimmune hair loss.

Nanoparticles with specific drugs can help regrow hair in alopecia areata.

In alopecia areata, certain immune cells increase and express a protein linked to immune activation.

Certain genes are linked to the risk of developing Alopecia Areata.

Alopecia areata is an incurable autoimmune condition causing hair loss, with research aiming for better treatments.

Alopecia areata is a common autoimmune disease affecting hair follicles, with unclear causes and a need for better treatments.

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.